Parasite Eyewear: The French Independent Brand That Reinvented the Frame
Most eyewear brands are variations on a theme: different proportions, different materials, different colourways — but the same fundamental logic. Parasite Eyewear started from a completely different question: what if the frame did not just sit on a face, but held it? The answer, in 2002, was four temples. And everything that followed has been built on that refusal to accept the existing format as fixed.

Parasite Design is a French eyewear company, founded by Hugo Martin in 2002 and still independent. It is not a brand that ended up in the hands of a luxury conglomerate. It is not distributed through multiples. It sells through a curated global network of independent optical boutiques — which is precisely where it belongs, and precisely where the dispensing conversation that does it justice can actually happen.
2002. Four temples. And a category that did not exist yet.
The founding innovation at Parasite was the STEREO active holding system — a four-temple design that holds the head in a fundamentally different way from any conventional frame. Not two temples but four. Not resting on the ears but actively engaging the skull. It was a structural reinvention of how eyewear connects to the human body, not a stylistic one.
That distinction matters. Many eyewear brands market themselves as innovative. Parasite was actually innovative in a way that required a new manufacturing approach, a new fitting conversation, and a patient willing to experience something genuinely unfamiliar. In 2002, that was a significant ask. It still is, which is exactly why it works as a differentiating stock choice for an independent practice in 2026.
The frames with four temples require a dispensing consultation that explains what they are doing and why. That conversation cannot happen in a corporate slot. It happens in the kind of practice that has time, expertise and the confidence to stock something that needs introduction.
Still independent. Still in France. Still uncompromising.
Parasite Design is based in Saint-Vulbas, in the Ain department of eastern France, not far from the Jura Mountains — the historic heartland of French eyewear manufacturing. This is not incidental. The brand manufactures in the Jura ateliers, using what it describes as the finest specialist workshops in France. Components and materials come from France, Italy and Germany. Everything is assembled and finished in France.
The design studio, C18, was founded by Hugo Martin and Timothée Panier. The studio combines 3D modelling expertise with a culture of experimentation, which explains both the precision of the finished product and the willingness to keep pushing format boundaries across each collection.
Parasite has also established a project called Perspective: an alternative manufacturing approach based on 3D printing, based in Oyonnax in partnership with specialist manufacturer Lucal, dedicated to eyewear, accessories and fashion. This is not a marketing concept. It is an active investment in a manufacturing method that the brand believes will shape the future of eyewear production.
Science fiction as a design brief. Not a marketing metaphor.
Parasite describes itself as a science-fiction-influenced, avant-garde, high-end eyewear brand. That is not a positioning statement. It is an accurate description of how the design process actually works.
The brand's stated design philosophy is symbiosis — physical symbiosis between the product and the wearer's body, and cultural symbiosis between the brand and the people who choose it. The product design style is described as a futuristic balance between sport and fashion. The broader design thinking engages explicitly with the concept of transhumanism — the idea that technology and the human body progressively merge.
For an optical practice, this translates into something concrete. A patient who picks up a Parasite frame is not picking up a fashion object. They are picking up a position. An attitude. A frame that makes a statement about who they are and what they think the future looks like. That kind of patient does not want to be processed. They want to be understood — and they will reward the practice that takes the time to understand them with long-term loyalty.
The award record. Read it once and then use it in the dispensing conversation.
Parasite has been recognised at Silmo d'Or in Paris — the international benchmark for eyewear design excellence — four times. The 2016 award was for best sunglass. The 2017 nomination was for best frame. The 2022 award was the Première Classe International Design Prize. In 2024, the brand received the jury's special prize — a recognition that sits outside the standard categories and is awarded at the jury's discretion for work it considers exceptional.
In Japan, where eyewear connoisseurship is arguably more rigorous than anywhere else in the world, Parasite won Eyewear of the Year at IOFT Tokyo in 2005, 2007, 2018 and 2019. Four times. That is not a brand that got lucky at a trade show. That is a brand that has sustained genuine recognition across two decades, in the most demanding market for independent eyewear in the world.
In New York, the NOW Awards nominated Parasite in the sunglasses category in both 2023 and 2024.
This award record is clinically useful. A dispensing optician who can say "this brand has won Silmo d'Or four times, including the jury's special prize in 2024, and has been Eyewear of the Year in Japan four times" is not doing a sales pitch. They are providing professional context. It is the same instinct that makes patients trust a clinical recommendation more than an advertisement.
Three collections. One philosophy.
Parasite's current range is organised into three distinct lines. The optical collection applies the brand's signature structural and material approach to prescription frames — including the four-temple STEREO system in designs that span the spectrum from wearable-daily to fully avant-garde. The sun collection brings the same design language to sunwear, with finishes and lens specifications that reflect the same attention to material quality as the optical range.
The third line is LAB — described by the brand as a seasonal experimental eyewear laboratory where design and technology meet art and fashion. LAB releases are special editions. They are not repeatable and not for every patient. They are for the patient in every independent practice who wants the thing nobody else has, because they got there first. Stocking LAB editions is a signal about what kind of practice you are running.
Why this brand belongs in an independent practice. And why can it not go anywhere else?
Parasite does not sell through multiples. The retail network is independent optical boutiques and specialist eyewear destinations. The store locator on the brand's website reflects a deliberately selective global footprint — practices that have led the brand to choose to stock items that require expertise to present and confidence to carry.
That exclusivity is the commercial argument. A patient who wants Parasite has to find an independent practice to buy it. There is no Specsavers option. There is no Vision Express version. The brand's distribution model is, structurally, a patient acquisition strategy for the practices that stock it — because it drives a specific kind of patient through the door. The patient who researches their eyewear. The patient who cares about provenance. The patient who will tell their friends.
The dispensing conversation that Parasite demands is also the conversation that independent practices are uniquely placed to have. The STEREO system needs explaining—what it does, why four temples work differently, and how the fit feels different from a conventional frame. The design philosophy needs context — the sci-fi influences, the manufacturing story, the award history. None of that fits in a corporate appointment. All of it fits the kind of practice that decided to go independent because they wanted to do things properly.
Parasite is not a brand for every patient. That is entirely the point.
Stockist enquiries and trade information: parasite-eyewear.com
Share
Related Posts
-

£24.13 a Sight Test: The NHS Backlog Is Real, the Fee Is Not
The NHS is paying £24.13 for a sight test. That is not a mistake. That is a choice. For the financial year 2025 to 20...
-

Optos MonacoPro: The Case for Ultra-Widefield OCT in Independent Practice
There are currently around 608,000 people on the NHS ophthalmology waiting list in England. Most of them did not star...


1 comment
That is some serious eyewear. Awesome